GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rhinomed Ltd (ASX:RNO) » Definitions » Short Percentage of Float

Rhinomed (ASX:RNO) Short Percentage of Float


View and export this data going back to 2007. Start your Free Trial

What is Rhinomed Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Rhinomed's Short Percentage of Float

For the Medical Devices subindustry, Rhinomed's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rhinomed's Short Percentage of Float Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rhinomed's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Rhinomed's Short Percentage of Float falls into.


Rhinomed (ASX:RNO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rhinomed Ltd (ASX:RNO) » Definitions » Short Percentage of Float
Comparable Companies
ASX:VTI ASX:IRX ASX:CBL ASX:HMD ASX:UCM ASX:OSL ASX:AT1 ASX:AMT ASX:LBT ASX:CSX ABT SYK MDT BSX EW SZSE:300760 DXCM ZBH ALGN STE
Traded in Other Exchanges
RHNMF:USA
Address
132 Gwynne Street, Level 1, Cremorne, VIC, AUS, 3121
Website
https://www.rhinomed.global
Rhinomed Ltd is a medical technology company, with a patented nasal technology platform. It is engaged in the research, development and commercialization of consumer and medical devices including nasal, respiratory and nasal drug delivery technologies. It operates in one segment which is the identification, acquisition, and commercialization of late-stage consumer therapeutic and medical delivery technologies. The products of the company involve Rhinoswab, Mute, Turbine and Rhinoswab Junior. It operates geographically within North, Central, and South America, Asia-Pacific, Europe, Middle East, and Africa. The company earns majority of its revenue from Asia-Pacific.

Rhinomed (ASX:RNO) Headlines

No Headlines